Adrian T. Ting

7.8k total citations · 1 hit paper
58 papers, 6.3k citations indexed

About

Adrian T. Ting is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Adrian T. Ting has authored 58 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 29 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Adrian T. Ting's work include NF-κB Signaling Pathways (22 papers), Cell death mechanisms and regulation (18 papers) and Immune Response and Inflammation (11 papers). Adrian T. Ting is often cited by papers focused on NF-κB Signaling Pathways (22 papers), Cell death mechanisms and regulation (18 papers) and Immune Response and Inflammation (11 papers). Adrian T. Ting collaborates with scholars based in United States, China and Spain. Adrian T. Ting's co-authors include Brian Seed, Chengyu Jiang, Marie Anne O’Donnell, Felipe X. Pimentel‐Muiños, Mathieu J.M. Bertrand, Ramnik J. Xavier, Aylwin Ng, Robert T. Abraham, Paul J. Leibson and Renee A. Schoon and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Adrian T. Ting

58 papers receiving 6.2k citations

Hit Papers

PPAR-γ agonists inhibit production of monocyte inflammato... 1998 2026 2007 2016 1998 500 1000 1.5k 2.0k 2.5k

Peers

Adrian T. Ting
Gabriel Pascual United States
Mingui Fu United States
Brydon L. Bennett United States
Anthony M. Manning United States
Heng Lin Taiwan
Lih‐Ling Lin United States
John S. Mudgett United States
Gabriel Pascual United States
Adrian T. Ting
Citations per year, relative to Adrian T. Ting Adrian T. Ting (= 1×) peers Gabriel Pascual

Countries citing papers authored by Adrian T. Ting

Since Specialization
Citations

This map shows the geographic impact of Adrian T. Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian T. Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian T. Ting more than expected).

Fields of papers citing papers by Adrian T. Ting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian T. Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian T. Ting. The network helps show where Adrian T. Ting may publish in the future.

Co-authorship network of co-authors of Adrian T. Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian T. Ting. A scholar is included among the top collaborators of Adrian T. Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian T. Ting. Adrian T. Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chawla, Yogesh, et al.. (2023). Sensitization of Tumor Cells to IFNy-Mediated Cell Death. The Journal of Immunology. 210(Supplement_1). 245.22–245.22. 1 indexed citations
2.
Chen, Lili, Zhengxiang He, Bernardo Sgarbi Reis, et al.. (2022). IFN-γ+ cytotoxic CD4+ T lymphocytes are involved in the pathogenesis of colitis induced by IL-23 and the food colorant Red 40. Cellular and Molecular Immunology. 19(7). 777–790. 22 indexed citations
3.
Ang, Rosalind L., Diana Legarda, John P. Sundberg, et al.. (2021). Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death. Proceedings of the National Academy of Sciences. 118(50). 11 indexed citations
4.
Chun, Nicholas, Robert L. Fairchild, William M. Baldwin, et al.. (2021). T cell–derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death. JCI Insight. 6(24). 10 indexed citations
5.
Xu, Xin, Matko Kalac, Joshua Brody, et al.. (2020). Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL). Cell Death and Disease. 11(2). 94–94. 20 indexed citations
6.
Priem, Dario, Michaël Devos, Arne Martens, et al.. (2019). A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms. Cell Death and Disease. 10(10). 60–60. 66 indexed citations
7.
Ang, Rosalind L. & Adrian T. Ting. (2018). Tumor necrosis factor-driven cell death in donor organ as a barrier to immunological tolerance. Current Opinion in Organ Transplantation. 24(1). 12–19. 10 indexed citations
8.
Ang, Rosalind L. & Adrian T. Ting. (2018). Detection of RIPK1 in the FADD-Containing Death Inducing Signaling Complex (DISC) During Necroptosis. Methods in molecular biology. 1857. 101–107. 2 indexed citations
9.
Ting, Adrian T., Lin Radigan, Jose Chavez, et al.. (2018). TACI Isoforms Regulate Ligand Binding and Receptor Function. Frontiers in Immunology. 9. 2125–2125. 19 indexed citations
10.
Cols, Montserrat, Adrian T. Ting, Lin Radigan, et al.. (2015). Differential induction of plasma cells by isoforms of human TACI. Blood. 125(11). 1749–1758. 30 indexed citations
11.
Rosebeck, Shaun, Aasia Rehman, Ingrid J. Apel, et al.. (2013). The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling. Oncogene. 33(19). 2520–2530. 25 indexed citations
12.
Lü, Jianfeng, Donna McEachern, Haiying Sun, et al.. (2011). Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment. Molecular Cancer Therapeutics. 10(5). 902–914. 51 indexed citations
13.
O’Donnell, Marie Anne & Adrian T. Ting. (2011). RIP1 comes back to life as a cell death regulator in TNFR1 signaling. FEBS Journal. 278(6). 877–887. 38 indexed citations
14.
O’Donnell, Marie Anne & Adrian T. Ting. (2010). Chronicles of a death foretold: Dual sequential cell death checkpoints in TNF signaling. Cell Cycle. 9(6). 1065–1071. 26 indexed citations
15.
Yang, Jianfei, Min Yang, Xinshou Ouyang, et al.. (2008). Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt. European Journal of Immunology. 38(5). 1204–1214. 84 indexed citations
16.
O’Donnell, Marie Anne, et al.. (2007). Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling. Current Biology. 17(5). 418–424. 241 indexed citations
17.
Zhang, Yue, Adrian T. Ting, Kenneth B. Marcu, & James B. Bliska. (2005). Inhibition of MAPK and NF-κB Pathways Is Necessary for Rapid Apoptosis in Macrophages Infected with Yersinia. The Journal of Immunology. 174(12). 7939–7949. 114 indexed citations
18.
Jiang, Chengyu, Adrian T. Ting, & Brian Seed. (1998). PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391(6662). 82–86. 2568 indexed citations breakdown →
19.
Ting, Adrian T., Larry M. Karnitz, Renee A. Schoon, Robert T. Abraham, & Paul J. Leibson. (1992). Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells.. The Journal of Experimental Medicine. 176(6). 1751–1755. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026